Cargando…
Comparison of the acceptability and safety of molnupiravir in COVID-19 patients aged over and under 80 years
BACKGROUND: Molnupiravir is being widely used as a treatment for coronavirus disease 2019 (COVID-19); however, its acceptability and safety in older patients aged ≥ 80 years in real-world clinical practice is not well understood. METHODS: We conducted a single-centre retrospective study and assessed...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Authors. Published by Elsevier B.V.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985534/ https://www.ncbi.nlm.nih.gov/pubmed/36919008 http://dx.doi.org/10.1016/j.ahr.2023.100130 |